In addition, they identified that DDP and paclitaxel could accelerate miR-522 secretion from CAFs by activating the USP7/hnRNPA1 axis and reduce the gross of lipid-ROS in GC cells by restraining ALOX15, which finally reduced chemosensitivity in vitro and in vivo. Here, ALOX15 is linked to gastric cancer.